We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.2M
2
XOM icon
ExxonMobil
XOM
+$10.8M
3
AAPL icon
Apple
AAPL
+$10.8M
4
IBB icon
iShares Biotechnology ETF
IBB
+$10.2M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$265M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$98.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$32.7M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$18.2M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.9M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMH
3551
DELISTED
Impac Mortgage Holdings Inc.
IMH
$2K ﹤0.01%
151
-3,906
-96% -$57.6K
OLO
3552
DELISTED
DB Crude Oil Long Exchange Traded Notes due June 1, 2038
OLO
$2K ﹤0.01%
+386
New +$1.75K
ACHC icon
3553
Acadia Healthcare
ACHC
$2.94B
$1K ﹤0.01%
40
-1,061
-96% -$41.2K
ADAP
3554
DELISTED
Adaptimmune Therapeutics
ADAP
$1K ﹤0.01%
288
-1,249
-81% -$5.99K
ALCO icon
3555
Alico
ALCO
$283M
$1K ﹤0.01%
+40
New +$1.09K
ANGI icon
3556
Angi Inc
ANGI
$196M
$1K ﹤0.01%
+8
New +$682
APVO icon
3557
Aptevo Therapeutics
APVO
$5.21M
– –
0
– –
ARCT icon
3558
Arcturus Therapeutics
ARCT
$211M
$1K ﹤0.01%
+92
New +$1.38K
ASG
3559
Liberty All-Star Growth Fund
ASG
$341M
$1K ﹤0.01%
347
-149
-30% -$621
ASRV icon
3560
AmeriServ Financial
ASRV
$83.5M
$1K ﹤0.01%
189
+89
+89% +$308
ASX icon
3561
ASE Group
ASX
$82.2B
$1K ﹤0.01%
200
-1,572
-89% -$8.73K
ATHE
3562
Alterity Therapeutics
ATHE
$80.7M
$1K ﹤0.01%
+51
New +$1.36K
ATLC icon
3563
Atlanticus Holdings
ATLC
$1.52B
$1K ﹤0.01%
297
-363
-55% -$1.1K
AWRE icon
3564
Aware
AWRE
$27.7M
$1K ﹤0.01%
119
-974
-89% -$5.38K
AWX icon
3565
Avalon Holdings
AWX
$10.1M
$1K ﹤0.01%
+400
New +$1.12K
AXGN icon
3566
Axogen
AXGN
$2.5B
$1K ﹤0.01%
+100
New +$862
BELFA icon
3567
Bel Fuse Inc Class A
BELFA
$3.37B
$1K ﹤0.01%
+20
New +$454
BGB
3568
Blackstone Strategic Credit 2027 Term Fund
BGB
$503M
$1K ﹤0.01%
+40
New +$596
BLFS icon
3569
BioLife Solutions
BLFS
$1.7B
$1K ﹤0.01%
+862
New +$1.39K
BN icon
3570
Brookfield
BN
$108B
$1K ﹤0.01%
98
-18,655
-99% -$227K
BWEN icon
3571
Broadwind
BWEN
$109M
$1K ﹤0.01%
+336
New +$1.43K
BXMT icon
3572
Blackstone Mortgage Trust
BXMT
$2.38B
$1K ﹤0.01%
30
-3,316
-99% -$98.7K
CDXS icon
3573
Codexis
CDXS
$158M
$1K ﹤0.01%
+303
New +$1.42K
CDZI icon
3574
Cadiz
CDZI
$291M
$1K ﹤0.01%
100
-314
-76% -$2.82K
CECO icon
3575
Ceco Environmental
CECO
$4.14B
$1K ﹤0.01%
+92
New +$1.12K
141 142
143
144 145

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.